What we do

Hereditary Sensory and Autonomic Neuropathies (HSAN) and Congenital Insensitivity to Pain (CIP) are rare disorders which result in the loss of pain as well as a variety of additional symptoms.

The rarity of the disorders results in small patient cohorts, a lack of standardized phenotypic information and low awareness, even among professionals, raising major hurdles for clinicians and scientists in treatment and research. As a result, patients and families often go through an odyssey of medical consultations and several years can pass until the diagnosis is made.

To overcome this, seven European research centers which focus on HSAN/CIP and two patient organizations have formed the European Network on Inherited Sensory Neuropathies and Insensitivity to Pain (ENISNIP). We aim to increase awareness of these rare disorders and to accelerate genetic testing and the discovery of new genes to improve patient care and diagnostics for long term.

On this website we would like to introduce the condition of HSAN/CIP, our work and the possibilites of contributing to our network, whether you are involved personally as a patient or family member or as a medical or scientific professional.